Pharma Mar SA (PHMMF)
94.60
0.00 (0.00%)
USD |
OTCM |
Sep 17, 16:00
Pharma Mar Cash from Operations (Quarterly) : 3.848M for June 30, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 3.848M |
| March 31, 2026 | 10.04M |
| December 31, 2025 | 39.00M |
| September 30, 2025 | 19.60M |
| June 30, 2025 | 9.861M |
| March 31, 2025 | -6.614M |
| December 31, 2024 | 1.666M |
| September 30, 2024 | 4.662M |
| June 30, 2024 | -9.916M |
| March 31, 2024 | 10.10M |
| December 31, 2023 | -2.890M |
| September 30, 2023 | -7.596M |
| June 30, 2023 | -12.45M |
| March 31, 2023 | 8.225M |
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | -0.6077M |
| March 31, 2022 | 40.18M |
| December 31, 2021 | 1.093M |
| September 30, 2021 | 12.54M |
| June 30, 2021 | -1.238M |
| March 31, 2021 | 17.29M |
| December 31, 2020 | 12.95M |
| September 30, 2020 | -0.3097M |
| June 30, 2020 | 101.35M |
| Date | Value |
|---|---|
| March 31, 2020 | 194.23M |
| December 31, 2019 | 0.7684M |
| September 30, 2019 | -12.76M |
| June 30, 2019 | -0.7079M |
| March 31, 2019 | -16.71M |
| December 31, 2018 | 4.134M |
| September 30, 2018 | 1.975M |
| June 30, 2018 | -14.56M |
| March 31, 2018 | -10.75M |
| December 31, 2017 | 0.6495M |
| September 30, 2017 | -2.802M |
| June 30, 2017 | -9.742M |
| March 31, 2017 | 9.819M |
| December 31, 2016 | 6.079M |
| September 30, 2016 | 2.844M |
| June 30, 2016 | -5.406M |
| March 31, 2016 | -13.03M |
| December 31, 2015 | 19.32M |
| September 30, 2015 | 4.305M |
| June 30, 2015 | -12.14M |
| March 31, 2015 | 0.616M |
| December 31, 2014 | 15.15M |
| September 30, 2014 | 7.583M |
| June 30, 2014 | -5.351M |
| March 31, 2014 | 11.18M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Oryzon Genomics SA | -- |
| Grifols SA | 265.35M |
| ACADIA Pharmaceuticals, Inc. | 100.78M |
| Alkermes Plc | 145.18M |
| Alnylam Pharmaceuticals, Inc. | 326.72M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -37.88M |
| Cash from Financing (Quarterly) | -0.0493M |
| Free Cash Flow | 62.89M |
| Free Cash Flow Per Share (Quarterly) | 0.0679 |
| Free Cash Flow to Equity (Quarterly) | 3.541M |
| Free Cash Flow to Firm (Quarterly) | 1.177M |
| Free Cash Flow Yield | 3.82% |